Welcome to the RECOVERED Study!
The RECOVERED study is a national study investigating Respiratory Syncytial Virus (RSV) vaccines in pregnancy and infant RSV monoclonal antibody.
Recruitment is now CLOSED. Thank you to everyone who participated!
Did you become pregnant in 2024?
Do you live in Canada?
We want to hear from you!
About the study
The RECOVERED Study is a Canada-wide study being conducted by the UBC Reproductive Infectious Diseases Program and is investigating Respiratory Syncytial Virus (RSV) vaccines in pregnancy and infant RSV monoclonal antibody. The RECOVERED study aims to broaden our understanding of vaccine attitudes, pregnancy outcomes, and infant outcomes related to maternal vaccination and infant monoclonal antibody for the prevention of severe RSV infection. The data are being collected from pregnant women and people, regardless of vaccination status. By gathering online survey data on knowledge and perception of RSV and feelings, opinions, and attitudes towards RSV vaccination and infant monoclonal antibody, this study will examine the acceptability, safety, and efficacy of these RSV prevention products among pregnant people in Canada. This information will be useful to public health officials deciding on public health programs, care providers recommending products to their patients, and future parents making informed health decisions during pregnancy.
Spread the word
Do you work with or are involved in organizations/activities with pregnant women and people and are you interested in helping with recruitment for RECOVERED? Click the button below to download French and/or English study recruitment materials that can be posted in medical clinics, prenatal classes, doula/midwifery centers among other public spaces to help people in your community get more info about this study!
